Overexpression of FGD5-AS1 has been identified in more malignant cancers, and deletion of FGD5-AS1 significantly reduces the migration, invasion, stemness, immune microenvironment, and proliferation of various tumor cells [21–24]. This evidence concerns the gene FGD5 and neoplasm.